114 results
Page 3 of 6
8-K
8csqbh n22kx
17 Jun 21
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
7:35am
8-K
EX-99.1
hsf kr6i9jdvffznlo9
13 May 21
Synlogic Reports First Quarter Financial Results and Provides Business Update
6:46am
8-K
dlkaukudgeq 7br8rk3
5 May 21
Entry into a Material Definitive Agreement
4:06pm
424B5
r238c 6bhkwu65jpj
19 Apr 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
tu1m31fzhtzbx0f
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
424B5
q0je x61rghoql4gpee3
15 Apr 21
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.1
gnigssvl2
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.2
vc06lbomnp9oj5i
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am
8-K
EX-99.1
c1k rdjiauytf
6 Aug 20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
7:00am
8-K
EX-99.1
in042 vwjl
8 May 20
Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update
7:15am
DEFA14A
21efz5c lvdha7
17 Apr 20
Additional proxy soliciting materials
4:10pm
8-K
EX-99.1
q9zqpa
12 Mar 20
Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:53pm